Cyclacel Pharmaceuticals Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Cyclacel Pharma (CYCC) Reports Q3 Loss of $0.08/Share
November 12, 2015 4:13 PM ESTCyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.08), versus ($0.22) reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
... More